news paper icon

Analyzed News

UPDATE 1-Novartis gains U.S. approval for delayed MS drug

* U.S. pricing pressure weighing on Sandoz (Adds detail, comment from analyst and company) [Source]

Publication Date:

Origin: reuters.com

Category: companyNews

Topics: 1-novartis, pricing, drug, delayed, gains

Source Link: http://feeds.reuters.com/~r/reuters/companyNews/~3/Eg41rcqO4Ho/update-1-novartis-gains-u-s-approval-for-delayed-ms-drug-idUSL8N1Q31IQ

Related Articles